Protalix Biotherapeutics Inc (PLX) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Protalix Biotherapeutics Inc · Cost of Revenue

PLX Cost of Revenue

Latest reported$24.83Mperiod endingJun 30, 2026

PLX Cost of Revenue ($0.00 → $24.83M)

Annual cost of revenue

High-resolution chart · PNG

PLX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	27,508,000
Dec 31, 2024	24,319,000
Dec 31, 2023	22,982,000
Dec 31, 2022	19,592,000
Dec 31, 2021	16,349,000
Dec 31, 2020	10,873,000
Dec 31, 2019	10,895,000
Dec 31, 2018	9,302,000
Dec 31, 2017	15,231,000
Dec 31, 2016	8,398,000
Dec 31, 2015	730,000
Dec 31, 2014	9,053,000
Dec 31, 2013	5,428,000
Dec 31, 2012	8,144,000
Dec 31, 2011	1,525,000
Dec 31, 2010	4,383,000
Dec 31, 2009	3,575,000
Dec 31, 2008	0
Dec 31, 2007	2,254,000
Dec 31, 2006	35,000
Dec 31, 2005	35,000
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	2,684,000
Dec 31, 1998	6,306,000
Dec 31, 1997	0
Dec 31, 1996	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.